LLY vs TMO
By Alex · Tickerpine
Eli Lilly and Company vs Thermo Fisher Scientific Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | TMO |
|---|---|---|
| Price | $1,443.50 | $700.22 |
| Market cap | $1.29T | $259.44B |
| P/E ratio | 46.9 | 36.9 |
| ROE | 86.02% | 13.38% |
| Profit margin | 31.90% | 14.94% |
| Revenue growth | 38.60% | 9.10% |
| Dividend yield | 0.48% | 0.27% |
| Beta | 0.39 | 0.84 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs TMO in plain English
- LLY is the bigger company — about 5.0× the market cap of TMO.
- TMO is cheaper on earnings (P/E 36.9 vs 46.9).
- LLY earns a higher return on equity (86% vs 13%).
- LLY is growing revenue faster (39% vs 9%).
- LLY has the higher dividend yield (0.48% vs 0.27%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.